Skip to content
2000
Volume 2, Issue 2
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Despite significant improvements in early detection and refinements of therapeutic protocols over the last several decades, cancer remains one of the leading causes of death in North America. In particular, treatment of metastatic cancers is a highly desirable and yet still elusive goal of the oncologist. One strategy which holds promise is the use of self replicating viral strains with the ability to specifically kill tumour but not normal cells. These so-called “oncolytic viruses” are in general, attenuated for growth in normal cells but are able to exploit tumour specific, genetic defects to gain a growth advantage. In this review, we will discuss the virus:host cell interactions which help form the niche occupied by oncolytic viruses. The current and potential clinical applications / limitations will be discussed for oncolytic viruses from the herpesvirus, adenoviruses, picornavirus, rhabdovirus, and paramyxovirus families.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523024605582
2002-05-01
2025-08-14
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523024605582
Loading

  • Article Type:
    Review Article
Keyword(s): Fibre Knob; Oncolytic Viruses; Paramyxoviruses; Tumour Hunters
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test